All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
CFRX / ContraFect Corp Put
|
|
|
|
|
|
|
|
STXS / Stereotaxis, Inc.
|
|
|
|
|
|
|
|
ELOX / Eloxx Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VERU / Veru Inc. Put
|
|
|
|
|
|
|
|
VRAYQ / ViewRay, Inc.
|
|
|
|
|
|
|
|
IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ALT / Altimmune, Inc.
|
|
|
|
|
|
|
|
PHR / Phreesia, Inc.
|
|
|
|
|
|
|
|
HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
RLMD / Relmada Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ESPR / Esperion Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
MCRB / Seres Therapeutics, Inc.
|
|
|
|
|
|
|
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
CGEN / Compugen Ltd.
|
|
|
|
|
|
|
|
MGTX / MeiraGTx Holdings plc
|
|
|
|
|
|
|
|
LVTX / LAVA Therapeutics N.V.
|
|
|
|
|
|
|
|
IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
RXDX / Prometheus Biosciences Inc Put
|
|
|
|
|
|
|
|
HGEN / Humanigen, Inc. Put
|
|
|
|
|
|
|
|
ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
SBTX / Silverback Therapeutics Inc
|
|
|
|
|
|
|
|
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
|
|
|
|
|
|
|
|
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
|
|
|
|
|
|
|
|
KYG5960S1241 / Medicus Sciences Acquisition Corp.
|
|
|
|
|
|
|
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
NCNA / NuCana plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
FMTX / Forma Therapeutics Holdings Inc
|
|
|
|
|
|
|
|
CGEM / Cullinan Therapeutics, Inc.
|
|
|
|
|
|
|
|
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc Put
|
|
|
|
|
|
|
|
PYPD / PolyPid Ltd.
|
|
|
|
|
|
|
|
APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc Put
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
CMPX / Compass Therapeutics, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
PYPD / PolyPid Ltd. Put
|
|
|
|
|
|
|
|
AVXL / Anavex Life Sciences Corp. Call
|
|
|
|
|
|
|
|
AVXL / Anavex Life Sciences Corp. Put
|
|
|
|
|
|
|
|
NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
CLNN / Clene Inc. Put
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
CVRX / CVRx, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PSTX / Poseida Therapeutics, Inc.
|
|
|
|
|
|
|
|
PNT / POINT Biopharma Global Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
NGM / NGM Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
TERN / Terns Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
|
|
|
|
|
TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
EVGN / Evogene Ltd.
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
NUVL / Nuvalent, Inc.
|
|
|
|
|
|
|
|
ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
CERS / Cerus Corporation
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
ELYM / Eliem Therapeutics, Inc.
|
|
|
|
|
|
|
|